Brandon Lu
4PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 08, 2025
Pembrolizumab vs. chemotherapy in the first-line setting of PD-L1 ≥ 50% metastatic non-small cell lung cancer: a real-world cost-effectiveness analysis.Brandon Liu, Ambica Parmar, Jin Luo
|Jun 11, 2024
Real-world comparative effectiveness and safety of pembrolizumab for PD-L1≥50% metastatic non-small-cell lung cancer.Ambica Parmar, Brandon Lu, Jin Luo
|Mar 31, 2023
Cost-effectiveness of second-line ipilimumab for metastatic melanoma: A real-world population-based cohort study of resource utilization.Brandon Lu, Wei Fang Dai, Ruth Croxford
|Dec 13, 2022
Use of Instrumental Variable Analyses for Evaluating Comparative Effectiveness in Empirical Applications of Oncology: A Systematic Review.Brandon Lu, Sasha Thomson, Scott Blommaert
Pageof 1
